Lipella Pharma (LIPO) - Uzoq muddatli qarzning kapitalga koeffitsiyenti

Lipella Pharma - LIPO emitenti grafik logotipi

Lipella Pharmaceuticals (LIPO) nish segmentidagi qat'iy patent himoyasidan foydalangan holda, sistitni davolovchi dori vositalarini maqsadli yetkazib berishning noyob usullarini ishlab chiqmoqda. Biznesning o'sishi qovuq o'smalarini davolashda LP-10 ning muvaffaqiyati va klinikalarga amalga oshirilgan hamkorliklarga asoslangan. Ushbu narxlar grafigi ko'rsatkichni 0.00 darajasida aks ettiradi. Operatsion barqarorlik diversifikatsiya qilingan xomashyo ta'minoti zanjirlari va ombor zaxiralarining tashkil etilishi orqali ta'minlanadi.

Lipella Pharmaceuticals Inc (LIPO): Uzoq muddatli qarzning o'z kapitaliga nisbati 28.04.2023dan 19.07.2025gacha

Lipella Pharmaceuticals (LIPO) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va konsensus maqsadli narx:
Kotirovkalar grafigi Lipella Pharmaceuticals Inc|LIPO - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Lipella Pharmaceuticals, Inc.|LIPO - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Lipella Pharmaceuticals|LIPO - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati lipella.com|LIPO - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Lipella Pharmaceuticals|LIPO - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati lipella.com|LIPO - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Lipella Pharmaceuticals, Inc.|LIPO - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Lipella Pharmaceuticals|Oraliq likvidlik koeffitsiyenti lipella.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
LIPO - Sof foyda
Kompaniyaning umumiy tahlili:Lipella Pharmaceuticals Inc - LIPO
Lipella Pharmaceuticals brend mahsuloti

Lipella Pharmaceuticals kompaniyasining innovatsion dori yetkazib berish tizimlarini ishlab chiqishi sezilarli uzoq muddatli investitsiyalarni talab qiladi. Bir yildan ortiq muddatga moliyalashtirilgan qarzdorlikning kapitalga nisbati tashqi moliyalashtirish va ichki resurslar o'rtasidagi muvozanatni aks ettiradi. Ushbu nisbatning pasayishi qarzdorlik yukining kamayganini va defolt xatarlarining yumshaganini ko'rsatadi. Haddan tashqari past leveraj o'sish uchun qarz kapitalidan yetarlicha foydalanilmaganligini anglatishi mumkin. Uzoq muddatli qarzdorlikning kapitalga nisbati dinamikasi bizga kompaniyaning moliyaviy barqarorligini baholash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

Haleon PLC - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati KVUE|VRNA (Verona Pharma Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati MENS (Jyong Biotech Ltd)|Uzoq muddatli qarzning kapitalga nisbati ligand.com LGND|AMRX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PRGO (Perrigo Company PLC)|Alvotech Corp (ALVO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Liquidia Inc.|GLPG (Galapagos NV) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati anipharmaceuticals.com|Uzoq muddatli qarzning o'z kapitaliga nisbati MNKD (MannKind)|AMPH (Amphastar Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Pacira PCRX|ARS Corp (SPRY) - Uzoq muddatli majburiyatlarning kapitalga nisbati|TBPH: Uzoq muddatli qarzning o'z kapitaliga nisbati|aquestive.com - Uzoq muddatli kreditlarning kapitalga nisbati|SCPH: Uzoq muddatli qarzning kapitalga nisbati|Tectonic Therapeutic - Uzoq muddatli qarzning kapitalga koeffitsiyenti|TNXP (Tonix Pharmaceuticals Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati SXT China SXTC|Uzoq muddatli qarzning o'z kapitaliga nisbati Eupraxia Pharmaceuticals (EPRX)|BHST (bioharvest.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati eXoZymes EXOZ|Oramed - Uzoq muddatli qarzning o'z kapitaliga nisbati|Entera Bio Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati MindWalk Therapeutics HYFT|ABVC BioPharma (ABVC) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati CPIX (cumberlandpharma.com)|QNTM (Quantum BioPharma) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati FibroGen Inc FGEN|Uzoq muddatli qarzning o'z kapitaliga nisbati Telomir Pharma (TELO)|Uzoq muddatli qarzning o'z kapitaliga nisbati RANI (ranitherapeutics.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati Synergy CHC SNYR|Rallybio Corp - Uzoq muddatli qarzning o'z kapitaliga nisbati|Lexaria - Uzoq muddatli qarzning kapitalga nisbati|PULM - Uzoq muddatli qarzning kapitalga nisbati|PTHL (ftzy.com.cn) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Aptorum Group - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Lyra Therapeutics, Inc.|impactbiomedinc.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati TNFA|YCBD (cbdmd.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati PRFX (PainReform Limited)|Uzoq muddatli qarzning kapitalga nisbati Altamira Therapeutics Ltd CYTO|OPTN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PIRS (pieris.com)|Procaps (PROC) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Petros Pharmaceuticals Inc|QLI (Qilian International Holding Group Limited) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ACELYRIN Inc.|Uzoq muddatli qarzning kapitalga nisbati TFFP